je.st
news
SCRA Technology Ventures Announces SBIR Match
2014-10-01 11:35:24| drugdiscoveryonline Home Page
SCRA Technology Ventures recently announced that Leukogene Therapeutics, Inc. (LTI) will receive a Phase I SBIR Match from its SC Launch program. LTI, a Charleston-based company, was newly accepted into the SC Launch program this month
Tags: technology
match
announces
ventures
Category:Biotechnology and Pharmaceuticals